Saylo Construction

Nam augue velit, fermentum sed erat non, efficitur interdum lectus. Donec hendrerit lorem a dui euismod tempus. Vivamus auctor blandit tellus et interdum.

Get In Touch
image
26 Mar

Laidlaw’s James Ahern Named to Crain’s New York Notable Leaders in Finance 2024

Read More
image
12 Dec

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

Read More
image
05 Dec

Laidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent Private Placement for Soleno Therapeutics (SLNO)

Read More
image
31 Mar

Laidlaw acts as Co-Manager on the $287,500,000 Follow-On Offering for Viking Therapeutics.

Read More
image
19 Dec

Laidlaw acts as Exclusive Introducing Broker on NLS Pharmaceutics’ Closing of Initial Tranche of US$10.0 Million Purchase Agreement with BVF Partners L.P.

Read More
image
05 Oct

Laidlaw acts as Sole Placement Agent on the $4,000,000 NLS Pharmaceutics Ltd. Private Placement

Read More
© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).